*Corresponding author:
Atsushi Imai, MD Institute of Endocrine Related Cancer, Matsunami General Hospital, Kasamatsu, Gifu 5016062, JapanReceived: November 01, 2017; Published: November 08, 2017
DOI: 10.26717/BJSTR.2017.01.000507
To view the Full Article Peer-reviewed Article PDF
Uterine fibroids (myomas) are very common affecting more than 60% of women over the age of 45 years [1,2]. Although many fibroids are asymptomatic, some may cause exhausting symptoms including heavy menstrual bleeding and pelvic pain. Submucosal fibroids, in particular pedunculated fibroids prolapsed into the vagina, are associated with heavy uterine bleeding and subsequent heavy anemia. The management of prolapsed pedunculated fibroid is determined by the origin and thickness of the pedicle, size, and its location. Uterine artery embolization (UAE) is increasingly being applied as a minimally invasive treatment alternative to surgery for the reduction of uterine fibroid symptoms [3]. UAEinduced depletion of blood flow through the whole myometrium and endometrium may be a useful adjunct to surgery for massive fibroids to reduce intraoperative blood loss [4].